Clinical Trial Update: HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial comparing HLA-mismatched hematopoietic stem cell transplantation to HLA-matched transplantation for intermed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED